Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zolpidem Maintenance Therapy for Chronic Insomnia
NCT03774810Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Apr 2019
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zolpidem in Insomnia (4 arms), sponsored by University of Pennsylvania. Primary endpoints: Treatment Response (Phase 1) at 1 Month, Insomnia Relapse (Phase 2) at 3 months and 1 more. Started Apr 2019; status: completed.
02
Drugs
zolpidem
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT03774810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03774810.